Clinical and economic consequences of bleeding following major orthopedic surgery

Thrombosis Research

Volumn 117, Issue 5, 2006, Pages 569-577

  Vera Llonch, Montserrat ^a   Hagiwara, May ^a   Oster, Gerry ^a  

^a POLICY ANALYSIS INC PAI   (United States)

Author keywords

Bleeding; Cost analysis; Costs; Hemorrhage; Orthopedic surgery; Outcomes; VTE

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; ECONOMIC ASPECT; FEMALE; HEMOGLOBIN DETERMINATION; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL RECORD; MULTIVARIATE ANALYSIS; ORTHOPEDIC SURGERY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; REOPERATION;

AGED; FEMALE; HOSPITAL CHARGES; HUMANS; INCIDENCE; INPATIENTS; LENGTH OF STAY; MALE; MULTIVARIATE ANALYSIS; ORTHOPEDIC PROCEDURES; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 33644647190     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.04.018     Document Type: Article

References (36)

1. G.P. Clagett, F.A. Anderson, and J. Heit Prevention of venous thromboembolism Chest 102 Supplement 4 1992 391S 407S
2. G.P. Clagget, F.A. Anderson, and J. Heit Prevention of venous thromboembolism Chest 108 Supplement 4 1995 312S 334S
3. National Institutes of Health Consensus Development Conference Prevention of venous thromboembolism. NIH consensus development JAMA 256 1986 744 749
4. D.A. Haake, and S.A. Berkman Venous disease after hip surgery. Risk factors, prophylaxis, and diagnosis Clin Orthop 242 1989 212 231
5. W.H. Geerts, J.H. Heit, and P. Clagget Prevention of venous thromboembolism Chest 119 2001 132S 175S
6. D.N. Mohr, M.D. Silverstein, and P.A. Murtaugh Prophylactic agents for venous thrombosis in elective hip surgery meta-analysis of studies using venographic assessment Arch Intern Med 153 1993 2221 2228
7. T.F. Imperiale, and T. Speroff A meta-analysis of methods to prevent VTE following total hip replacement JAMA 271 1994 1780 1785
8. R. Hull, G. Raskob, and G. Pineo A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation N Engl J Med 329 1993 1370 1376
9. A.G. Turpie, K.A. Bauer, and B.I. Eriksson Fondaparinux vs. enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies Arch Intern Med 162 16 2002 1806 1808
10. M.R. Lassen, K.A. Bauer, and B.I. Eriksson Post-operative fondaparinux vs. preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomized double-blind comparison Lancet 359 2002 1715 1720
11. A.G.G. Turpie, K.A. Bauer, and B.I. Eriksson Post-operative fondaparinux vs. post-operative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomized double-blind trial Lancet 2002 1721 1726
12. A.G.G. Turpie, A.S. Gallus, and J.A. Hoek A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement N Engl J Med 344 9 2001 619 625
13. Atlas Scoring: A Technical White Paper. Marlborough, MA: MediQual Systems (Cardinal Information Corporation), February 1996.
14. P.M. Steen Approaches to predictive modeling Ann Thorac Surg 58 1994 1836 1840
15. L.I. Iezzoni, A.S. Ash, G.A. Coffman, and M.A. Moskowitz Predicting in-hospital mortality: a comparison of severity measurement approaches Med Care 30 1992 347 359
16. L.I. Iezzoni The risks of risk adjustment JAMA 278 1997 1600 1607
17. N. Duan Smearing estimate: a nonparametric retransformation method J Am Stat Assoc 78 383 1983 605 610
18. G.E. Raskob, and J. Hirsch Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery Chest 124 2003 379S 385S
19. D.L. Bhatt, B.I. Lee, and P.J. Casterella Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the coronary revascularization using integrilin and single bolus enoxaparin study J Am Coll Cardiol 41 1 2003 988 992
20. V.H. Boujida, T. Philipsen, and J. Pelle Five-year follow-up of endometrial ablation: endometrial coagulation vs. endometrial resection Obstet Gynecol 99 6 2002 982 988
21. M.M. Mandani, C.M. Weingarten, and J.F. Stevenson Thromboembolic prophylaxis in moderate-risk patients undergoing elective abdominal surgery: decision and cost-effective analysis Pharmacotherapy 16 1996 1111 1127
22. A.F. Shorr, and A.S. Ramage Enoxaparin for thromboprophylaxis after major trauma: potential cost implications Crit Care Med 29 2001 1659 1665
23. R.D. Hull, G.E. Pineo, and G.E. Raskob The economic impact of treating deep vein thrombosis with low molecular weight heparin: outcome of therapy and health economics aspects Haemostasis 28 Suppl 3 1998 8 16
24. R.D. Hull, G.E. Raskob, and G.F. Pineo Subcutaneous low-molecular-weight heparin vs. warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective Arch Intern Med 157 1997 298 303
25. M. Marchetti, A. Pistorio, M. Barone, S. Serafini, and G. Barosi Low-molecular-weight heparin vs. warfarin for secondary prophylaxis of venous thromboembolism: a cost-effectiveness analysis Am J Med 111 2001 130 139
26. R.J. Friedman, and G.A. Dunsworth Cost analyses of extended prophylaxis with enoxaparin after arthroplasty Clin Orthop 370 2000 171 182
27. G.D. Paiement, S.J. Wessinger, and W.H. Harris Cost-effectiveness of prophylaxis in total hip replacement Am J Surg 161 1991 519 524
28. D.W. Haawkins, P.C. Langley, and K.P. Krueger A pharmacoeconomic assessment of enoxaparin and warfarin as prophylaxis for deep vein thrombosis in patients undergoing knee replacement surgery Clin Ther 20 1998 182 195
29. B.I. Eriksson, P. Wille-Jorgensen, and P. Kalebo A comparison of recombinant hirudin with a low-molecular-weight-heparin to prevent thromboembolic complications after total hip replacement N Engl J Med 337 1997 1329 1335
30. J.R. Leclerc, W.H. Gearts, and L. Desjardins Prevention of venous thromboembolism after knee arthroplasty: a randomized, double-blind trial comparing enoxaparin with warfarin Ann Intern Med 124 1996 616 628
31. T.E. Spiro, C.J. Johnson, and M.J. Christie Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery Ann Intern Med 121 1994 81 89
32. R. Hull, G. Raskob, and G. Pineo A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against DVT after hip or knee implantation N Engl J Med 329 1993 1370 1376
33. J.R. Leclerc, W.H. Geerts, and L. Desjardins Prevention of deep vein thrombosis after major knee surgery: a randomized, double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo Thromb Haemost 67 4 1992 417 423
34. M.H. Levine, J. Hirsch, and M. Gent Prevention of deep vein thrombosis after elective hip surgery: a randomized trial comparing low molecular weight heparin with standard unfractionated heparin Ann Intern Med 114 1991 545 551
35. P.F. Leyvraz, F. Bachmann, and J. Hoek Prevention of deep vein thrombosis after hip replacement: randomized comparison between unfractionated heparin and low molecular weight heparin BMJ 303 1991 543 548
36. A.G.G. Turpie, M.N. Levine, and J. Hirsch A randomized controlled trial of low-molecular weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery N Engl J Med 31 1986 925 929